UPDATE : Monday, August 10, 2020
JW Shinyak launches new hand eczema treatment
JW Shinyak, a subsidiary of JW Holdings, said on Thursday that it has launc...
by Lee Han-soo  |  2020-02-27 16:50
FDA OKs 2 phase-3 clinical trials for Gilead's Remdesivir
Gilead Sciences said Wednesday that it has begun two phase-3 clinical trial...
by Shim Hyun-tai  |  2020-02-27 16:08
Alvogen Korea wins anti-bribery system certification
Alvogen Korea said that it has acquired the ISO37001, an anti-bribery manag...
by Lee Han-soo  |  2020-02-27 12:10
Huons Global posts ₩449.4 billion in 2019 sales
Huons Global said that it posted 449.4 billion won ($369.5 million) in sale...
by Lee Han-soo  |  2020-02-26 16:15
US begins to test remdesivir for COVID-19 treatment
Following China, the U.S. has begun a clinical trial on remdesivir, Gilead’...
by Kim Yun-mi  |  2020-02-26 15:21
Novo Nordisk’s Saxenda remains at top in obesity treatment sales
Novo Nordisk Korea said Thursday that its obesity treatment injection, Saxe...
by Shim Hyun-tai  |  2020-02-25 18:12
Will Korean COVID-19 patients get to use remdesivir for compassionate use?
With new outbreaks of the novel coronavirus (COVID-19) spiked in Korea with...
by Kim Yun-mi  |  2020-02-24 17:41
Local researchers find new cause of Parkinson’s disease
A joint research team has discovered that if the function of a causative ge...
by Shim Hyun-tai  |  2020-02-21 18:25
Labor group slams Fresenius for allegedly breaching labor law
The Korean offshoot of Germany-based Fresenius Medical Care has violated em...
by Kim Yun-mi  |  2020-02-21 16:39
‘Favipiravir not approved as new coronavirus drug yet’
Some local news reports said -- mistakenly -- favipiravir, an experimental ...
by Kim Yun-mi  |  2020-02-21 12:08
Theragen Etex marked record-high sales, net profits in 2019
Theragen Etex said Thursday it hit record-high sales of 138.7 billion won (...
by Lee Han-soo  |  2020-02-20 18:48
Regulator OKs Pfizer's Vizimpro as 1st-line treatment of mutated lung cancer
Pfizer Korea said Thursday that the Ministry of Food and Drug Safety has ap...
by Shim Hyun-tai  |  2020-02-20 18:47
Daewoong’s Nabota gets item license in Brazil
Daewoong Pharmaceutical said Thursday that its botulinum product, Nabota, h...
by Shim Hyun-tai  |  2020-02-20 16:11
Drugmakers rush to roll out famotidine to replace ranitidine
Local pharmaceutical companies are quickly releasing medicines containing f...
by Jeong Sae-im  |  2020-02-18 15:07
Medytox's Meditoxin gets new indication for cervical dystonia
Medytox said Tuesday that its botulinum toxin preparation, Meditoxin, has r...
by Shim Hyun-tai  |  2020-02-18 15:06
JW wins US patent for world’s 1st multi-biomarker diagnostic kit
JW Holdings said Monday that it has obtained a patent in the United States ...
by Shim Hyun-tai  |  2020-02-17 17:54
Genexine’s US affiliate gets FDA nod for immune booster trial
NeoImmuneTech, Genexine's affiliate, received approval from the U.S. Fo...
by Shim Hyun-tai  |  2020-02-17 12:46
Helixmith gets mixed results from p3-1 trials of gene therapy
Helixmith said Friday that the clinical trial phase 3-1 result of Engensis ...
by Shim Hyun-tai  |  2020-02-14 18:12
Eisai to pull out antiobesity drug Belviq from US market
Eisai Pharmaceutical, a Japan-based multinational drug firm, has decided to...
by Lee Han-soo  |  2020-02-14 16:38
Daewoong’s sales reached ₩1 trillion milestone in 2019
Daewoong Pharmaceutical said that its sales exceeded 1 trillion won ($845.8...
by Lee Han-soo  |  2020-02-14 14:33
Back to Top